Correlation Between Exelixis and Blueprint Medicines
Can any of the company-specific risk be diversified away by investing in both Exelixis and Blueprint Medicines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Exelixis and Blueprint Medicines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Exelixis and Blueprint Medicines Corp, you can compare the effects of market volatilities on Exelixis and Blueprint Medicines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Exelixis with a short position of Blueprint Medicines. Check out your portfolio center. Please also check ongoing floating volatility patterns of Exelixis and Blueprint Medicines.
Diversification Opportunities for Exelixis and Blueprint Medicines
0.53 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Exelixis and Blueprint is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Exelixis and Blueprint Medicines Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Blueprint Medicines Corp and Exelixis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Exelixis are associated (or correlated) with Blueprint Medicines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Blueprint Medicines Corp has no effect on the direction of Exelixis i.e., Exelixis and Blueprint Medicines go up and down completely randomly.
Pair Corralation between Exelixis and Blueprint Medicines
Given the investment horizon of 90 days Exelixis is expected to generate 0.92 times more return on investment than Blueprint Medicines. However, Exelixis is 1.09 times less risky than Blueprint Medicines. It trades about 0.24 of its potential returns per unit of risk. Blueprint Medicines Corp is currently generating about 0.02 per unit of risk. If you would invest 2,582 in Exelixis on August 28, 2024 and sell it today you would earn a total of 1,056 from holding Exelixis or generate 40.9% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Exelixis vs. Blueprint Medicines Corp
Performance |
| Timeline |
| Exelixis |
| Blueprint Medicines Corp |
Exelixis and Blueprint Medicines Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Exelixis and Blueprint Medicines
The main advantage of trading using opposite Exelixis and Blueprint Medicines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Exelixis position performs unexpectedly, Blueprint Medicines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Blueprint Medicines will offset losses from the drop in Blueprint Medicines' long position.| Exelixis vs. TG Therapeutics | Exelixis vs. Viking Therapeutics | Exelixis vs. Madrigal Pharmaceuticals | Exelixis vs. BioXcel Therapeutics |
| Blueprint Medicines vs. Eliem Therapeutics | Blueprint Medicines vs. HCW Biologics | Blueprint Medicines vs. Scpharmaceuticals | Blueprint Medicines vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |